research Assessment of the therapeutic efficacy of botulinum toxin in male androgenetic alopecia
Botulinum toxin injections do not help with male pattern baldness.
Search
for
Sort by
Research
570-600 / 1000+ results
research Efficacy of Botulinum Toxin in Male Androgenetic Alopecia: a Triple-Blind, Randomized Clinical Trial
Botulinum toxin may help treat male pattern baldness.
research Assessment of cardiovascular risk factors in male androgenetic alopecia: A case control study in a tertiary care hospital of western Odisha
Men with male pattern baldness may have a higher risk of heart problems.
research Australian dermatologists' prescribing behaviours for male androgenetic alopecia
Australian dermatologists are updating their prescriptions for male pattern baldness.
research COMPLEX APPROACH TO THE TREATMENT OF ANDROGENETIC ALOPECIA IN MALE PERSONS WITH A POOR PROGNOSIS OF THE DISEASE
A new method for treating male pattern baldness in men with a low chance of improvement was discussed.
research A study of efficacy of platelet rich plasma in treatment of androgenetic alopecia in male patients
PRP is effective in treating male pattern baldness.
research Single-cell transcriptomics reveals hair growth retardation mediated by aberrant connective tissue sheath contraction in male androgenetic alopecia
Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.
research Global expression profile and global genome methylation signatures in male patients with androgenetic alopecia
Differences in gene expression and methylation patterns found in AGA patients suggest potential targets for future treatments.
research Topical 4‐Aminopyridine 5% in Male Androgenetic Alopecia: A Split‐Scalp Exploratory Series
Topical 4-aminopyridine 5% does not improve hair growth in male pattern baldness.
research Beyond Minoxidil: Evidence-Based Off-Label Therapies for Male Androgenetic Alopecia
Some off-label treatments may be effective for male pattern baldness.
research Comparative Study of effectiveness of low dose Oral Minoxidil vs Topical Minoxidil (5%) in Male Androgenetic Alopecia.
Low-dose oral minoxidil is more effective and convenient for treating male pattern baldness than topical minoxidil.
research Telogen effluvium, a curious case mimicking male androgenetic alopecia
Accurate diagnosis is crucial to distinguish telogen effluvium from male pattern baldness to avoid unnecessary treatments.
research Is the Addition of Oral Biotin to PRP More Beneficial for Treating Male Pattern Hair Loss Compared to PRP Alone? A Randomized Control Trial
Adding Biotin to PRP does not improve hair regrowth for male pattern baldness.
research Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.
research CHAPTER 21 Platelet-Rich Plasma and Microneedling in Male Pattern Hair Loss
Microneedling with PRP can boost hair growth in certain hair loss conditions.
research Comparative Study of Exosome Therapy Versus Platelet-Rich Plasma in Male Patients with Androgenetic Alopecia: A Prospective Clinical Study from Patna Medical College and Hospital, Patna, India
Exosome therapy is more effective than platelet-rich plasma for hair growth in male pattern baldness.
research Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review
Dutasteride is more effective than finasteride for hair regrowth in male and female pattern hair loss, with similar side effects.
research Short sequence repeats of the intergenic spacer regions of ribosomal RNA genes in Malassezia globosa and M. restricta colonizing the scalps of male individuals with and without androgenetic alopecia
A specific DNA pattern in Malassezia restricta may be linked to hair loss in men.
research Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.
Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.
research Characteristics of Hypertrichosis Induced by 24-week Low-dose (5 mg Daily) Oral Minoxidil in Male Pattern Hair Loss Treatment
Low-dose oral minoxidil often causes excess hair growth but doesn't significantly affect quality of life.
research Female pattern baldness in men
Some men can have female pattern baldness without hormonal abnormalities or signs of feminization.
research Male baldness; association with coronary artery disease?
Male baldness is not significantly associated with coronary artery disease.
research SERUM-CONCENTRATIONS OF DEHYDROEPYAN- DROSTERONE-SULFATE IN MEN WITH ANDROGE- NETIC ALOPECIA
Men with androgenetic alopecia do not have elevated DHEA-S levels.
research Histopathology of alopecia: a clinicopathological approach to diagnosis
The conclusion is that accurate diagnosis of different types of hair loss requires good teamwork between skin doctors and lab experts.
research Stem cells and alopecia: a review of pathogenesis
Damaged hair follicle stem cells can cause permanent hair loss, but understanding their role could lead to new treatments.
research Histopathologic Evaluation of Alopecias
The document concludes that accurate diagnosis of different types of hair loss requires careful examination of hair and scalp tissue, considering both clinical and microscopic features.
research Molecular Genetics of Alopecias
Scientists have found specific genes linked to different hair loss conditions, which could lead to new treatments.
research Valproic acid and alopecia: A two-edged sword
Valproic acid can cause hair loss when taken orally but may promote hair growth when applied topically.
research Alopecia and the Aging Male
Male pattern baldness is common, treatable, and may be linked to heart disease and prostate cancer.
research Comorbidities of Primary Scarring Alopecias: A Retrospective Multi‐Site Cross‐Sectional Study
People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.